Table 3.

Post-operative outcomes and UI outcomes at both short- and mid-term follow-up.

Variables	n = 925
Follow-up
Duration of f-up, months, median (IQR)	17 (11-27)
Biochemical recurrence (BCR)at last follow-up	63 (6.8)
-Of patients with BCR:
-adjuvant radiotherapy (in 10 cases concomitant ormonotherapy)	27 (42)
-salvage radiotherapy	8 (12)
-systemic ormonotherapy	9 (14)
Early (30 day) continence rate, n (%) *
Fully continent, no pad/die	766 (82.8)
1 or more pads/dies	159 (17.2)
Patients with moderate/severe incontinence within 30 days
2 pads/dies	125 (78.6)
3 pads/dies	26 (16.4)
>3 pads/dies	8 (5)
Continence at last follow-up days, n (%)
Fully continent, no pad/die	885 (95.5)
1 or more pads/dies	40 (5.5)
Patients with moderate/severe incontinence after 30 days
2 pads/dies	25 (62.5)
3 pads/dies	14 (35)
>3 pads/dies	1 (2.5)
Clavien–Dindo (CD) > 2 (within 30 days), n (%)
CD IIIa (10 cases requiring percutaneous drainage for symptomatic lymphocele and 5 requiring endoscopic catheter positioning for mdc spread)	15 (1.6)
CD IIIb (1 case clot retention requiring endoscopic evacuation and 1 case requiring re-intervention for uretrovesical anastomosis)	2 (0.2)
CD IV (1 case of post-operative cerebrovascular ischemia requiring neurovascular thrombolysis)	1 (0.1)
Claviend Dindo (CD) > 2 after 30 days), n (%)
CD IIIa (13 cases requiring percutaneous drainage for symptomatic lymphocele, 5 percutaneous drainages for abdominal abscessus)	18 (1.9)
CD IIIb (13 endoscopic urethrotomy for endoscopic stricture, 4 paraumbilical haernia requiring surgical repair, 1 re-operation for bladder repair, 1 case requiring re-intervention for uretrovesical anastomosis and 1 case requiring endoscopic surgery for clip removal)	20 (2.1)
CD IV (1 case of acute abdomen for bowel strangulation)	1 (0.1)

* Evaluated on patients for whom it is possible to recover data on continence (n = 873) also by means of a remote interview.